Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0239 per EA under NDC 67877093101. Its NADAC has been published 42 times since Nov 5, 2025.
FDA first approved this application on Dec 3, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877093101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213320FDA Approved
12/3/2021
TE Code
AB
On Market Since
8/25/2025
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 42 times since Nov 5, 2025, and over the history we have for it it has risen 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0239 per EA |
|---|---|
| All-time high | $0.0248 (Jun 10, 2026) |
| All-time low | $0.0226 (Nov 5, 2025) |
| 52-week high | $0.0248 |
| 52-week low | $0.0226 |
| Median price | $0.0245 |
| Average price | $0.0241 |
| Largest weekly change | -2.7% (Aug 19, 2026) |
| Weeks tracked | 42 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0239 per EA (NDC 67877093101), effective Aug 19, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has risen 5.9%. It has been tracked across 42 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Nov 5, 2025, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0226 (Nov 5, 2025) to a high of $0.0248 (Jun 10, 2026), with a median of $0.0245 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL 850 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 67877093101) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.